The Daily Insight

Connected.Informed.Engaged.

Ortho’s global corporate offices are in Raritan, New Jersey, while their global research and development center is in Rochester, New York. In 2014, The Carlyle Group purchased the company from Johnson & Johnson for $4.15 billion. Ortho Clinical Diagnostics now operates as an independent company.

Is Ortho Clinical Diagnostics a good company?

Ortho ranked No. 1 in the Health Care Equipment & Services category and No. 20 Of the 500 mid-size companies on the list. “We are proud to have once again been named by Forbes as one of America’s Best Mid-Sized Employers,” said Gary Passman, head of Global People & Culture, Ortho Clinical Diagnostics.

Is Ortho Clinical Diagnostics part of J&J?

Johnson & Johnson announced Thursday that it is selling its Ortho-Clinical Diagnostics business for $4.2 billion to the Carlyle Group. Based in Raritan, New Jersey, the Ortho-Clinical Diagnostics business makes in-vitro diagnostics products and operates in 130 countries.

How many employees does Ortho Clinical Diagnostics have?

4,4002019
Ortho Clinical Diagnostics/Number of employees

Is Ortho Clinical Diagnostics profitable?

Ortho Clinical Diagnostics Holdings is bordering on breakeven, according to the 8 American Medical Equipment analysts. They anticipate the company to incur a final loss in 2021, before generating positive profits of US$36m in 2022. Therefore, the company is expected to breakeven roughly a year from now or less!

Who is the CEO of Ortho Clinical Diagnostics?

Chris Smith
Chris Smith, chief executive officer of Ortho Clinical Diagnostics, has more than 30 years of health care sector experience and a proven track record driving value creation for multinational businesses.

What does Ortho Clinical Diagnostics do?

Ortho Clinical Diagnostics is a leading global provider of in vitro diagnostics. We have an established track record for providing high-quality products and services to the global clinical laboratory and immunohematology communities.

When did J&J sell Ortho Clinical Diagnostics?

New Brunswick, NJ, June 30, 2014 — Johnson & Johnson (NYSE: JNJ) today announced that it has completed the divestiture of its Ortho-Clinical Diagnostics business to The Carlyle Group for approximately $4 billion, subject to customary adjustments.

Who is the CEO of Orthopaedic?

Andrew Miller
It is our great pleasure to announce OrthoNorCal’s new Chief Executive Officer (CEO), Andrew Miller. He replaces Karen Sollar who will move on to Mt. Tam Orthopedics. Andrew Miller joins OrthoNorCal with more than twenty years of experience developing and managing healthcare organizations.

What does Ortho mean in Latin?

Ortho- (prefix): Prefix meaning straight or erect. From the Greek “orthos” that means just that: straight or erect.

How is in vitro testing done?

In-vitro testing removes a small bit of tissue from a living body and tests the tissue itself, leaving the living organism safe and sound. The Latin term in vitro means “in glass” and refers to the tissues being tested in glass test tubes. In-vitro testing is one of the many alternative options to avoid animal testing.

Where is the headquarters of Ortho Clinical Diagnostics located?

Ortho Clinical Diagnostics headquarters is located at 1001 US Route 202, Raritan. Where are Ortho Clinical Diagnostics offices? Ortho Clinical Diagnostics has offices in Raritan and Rochester.

Who are Ortho Clinical Diagnostics competitors?

Competitors of Ortho Clinical Diagnostics include United Imaging Healthcare, Masimo and Tecan Group. Where is Ortho Clinical Diagnostics headquarters? Ortho Clinical Diagnostics headquarters is located at 1001 US Route 202, Raritan.

What is the vision of Ortho Clinical Diagnostics?

Our vision represents the individual strengths of the three companies within our franchise: Ortho Clinical Diagnostics, Therakos and Veridex. It also brings us together to focus on what matters most – our employees and the people we serve.

What is the market capitalization of Ortho Clinical Diagnostics?

Ortho Clinical Diagnostics’s current market capitalization is $4.7 b. Feb, 2021 Mar, 2021 Apr, 2021 May, 2021 Jun, 2021 Jul, 2… Feb 21 Mar 07 Mar 21 Apr 04 Apr 18 May 16 May 30 Jun 13 Jun 27 Jul 11 Jul 25 Aug 08 Sep ’18 Apr ’19 Nov ’19 Jun ’20 Jan ’21 A…